UNIVERSITY OF CHICAGO – EDWARD NAURECKAS, MD
Supporting innovative pulmonary research focused on cystic fibrosis, bronchiectasis, NTM, asthma, and COPD through multidisciplinary collaboration, microbiome research, and clinical excellence.
Edward Naureckas, MD
Principal Investigator
University of Chicago
Institution
Airways Disease Research Program
Research & Clinical Program
Project Overview
The University of Chicago conducts multidisciplinary research focused on airway diseases including cystic fibrosis, bronchiectasis, NTM, asthma, and COPD. The center combines clinical care delivery research with collaborative multicenter trials and microbiome-focused investigations to improve patient outcomes and advance pulmonary medicine.
Project Summary
Under the leadership of Edward Naureckas, MD, the research team conducts studies in broad categories of airway disease with a strong focus on bronchiectasis, cystic fibrosis, asthma, COPD, and NTM. The program collaborates with national research networks and utilizes resources from the University of Chicago Microbiome Center to support innovative pulmonary research and evidence-based clinical care.
Project Goals
- Improve care delivery and outcomes for patients with airway diseases
- Advance bronchiectasis and NTM research initiatives
- Expand multidisciplinary pulmonary and microbiome research
Impact
The University of Chicago’s pulmonary research initiatives continue to improve understanding and treatment of chronic airway diseases. Ongoing collaborations with national organizations and participation in multicenter clinical trials support innovation in bronchiectasis, cystic fibrosis, asthma, COPD, and NTM management while advancing evidence-based patient care.
Advancing Research. Improving Lives.
Supporting innovative pulmonary research that drives better outcomes for patients with chronic airway diseases and NTM-related conditions.
EDWARD NAURECKAS, MD
Email: enaureck@uchicago.edu
Project Overview
The University of Chicago conducts multidisciplinary research focused on bronchiectasis, NTM, cystic fibrosis, asthma, and COPD to improve patient care and advance pulmonary medicine.